Kolexia
Mocquot François
Pharmacien
Ehpad Victor Nicolai
Peille, France
18 Activités
70 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Aggravation clinique Inflammation Pneumopathie infectieuse Embolie pulmonaire Maladie grave Embolie Surinfection Néovascularisation pathologique Hyperthyroïdie

Industries

ViiV Healthcare
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Media Room - Lemer Pax
LEMERPAX   10 octobre 2023
Quantitative analysis of Tc-pertechnetate thyroid uptake with a large-field CZT gamma camera: feasibility and comparison between SPECT/CT and planar acquisitions.
EJNMMI physics   31 juillet 2023
Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deterioration.
Therapeutic advances in respiratory disease   02 mai 2022
MIND: Microvascular Injury With Secondary Edema, and Distal Peripheral Vascular Thrombosis Contribution to Clinical Deterioration of Non-critically Ill Patients Hospitalized for SARS-CoV-2 Pneumonia Without Evidence of Pulmonary Embolism: a Preliminary Prospective Observational Study
Essai Clinique (Centre Hospitalier Princesse Grace)   08 mars 2022
QUANTHYC: Quantitative Analysis of 99mTc-Pertechnetate Thyroid Uptake With a Large Field CZT Gamma Camera: Feasibility and Comparison Between SPECT/CT and Planar Acquisitions
Essai Clinique (Centre Hospitalier Princesse Grace)   09 septembre 2021
In vivo monitoring of the therapeutic efficacy of a CXCR1/2 inhibitor with 18F-FDG PET/CT imaging in experimental head and neck carcinoma: A feasibility study.
Biochemistry and biophysics reports   12 août 2021
An Intravenous 100-mL Lipid Emulsion Infusion Dramatically Improves Myocardial Glucose Metabolism Extinction in Cardiac FDG PET Clinical Practice.
Clinical nuclear medicine   20 mai 2021
Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT: Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose
Essai Clinique (Centre Hospitalier Princesse Grace)   06 novembre 2020
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}